Departments of *Immunogenetics, †Molecular Pathology, Graduate School of Medical Sciences; ‡Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan; §Microbiological Research Institute, Otsuka Pharmaceutical Co. Ltd., Tokushima, Japan; and ‖The Nishimura Project Laboratory, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan.
Inflamm Bowel Dis. 2017 Dec;23(12):2121-2133. doi: 10.1097/MIB.0000000000001282.
Homozygous HLA-DR4/I-E transgenic mice (tgm) spontaneously developed colitis similar to human ulcerative colitis. We explored whether endoplasmic reticulum stress in colonic epithelial cells due to overexpression of HLA-DR4/I-E was involved in the pathogenesis of colitis.
Major histocompatibility complex class II transactivator-knockout (CIITAKO) background tgm were established to test the involvement of HLA-DR4/I-E expression in the pathogenesis of colitis. Histological and cellular analyses were performed and the effect of oral administration of the molecular chaperone tauroursodeoxycholic acid (TUDCA) and antibiotics were investigated. IgA content of feces and serum and presence of IgA-coated fecal bacteria were also investigated.
Aberrantly accumulated HLA-DR4/I-E molecules in colonic epithelial cells were observed only in the colitic homozygous tgm, which was accompanied by upregulation of the endoplasmic reticulum stress marker Binding immunoglobulin protein (BiP) and reduced mucus. Homozygous tgm with CIITAKO, and thus absent of HLA-DR4/I-E expression, did not develop colitis. Oral administration of TUDCA to homozygotes reduced HLA-DR4/I-E and BiP expression in colonic epithelial cells and restored the barrier function of the intestinal tract. The IgA content of feces and serum, and numbers of IgA-coated fecal bacteria were higher in the colitic tgm, and antibiotic administration suppressed the expression of HLA-DR4/I-E and colitis.
The pathogenesis of the colitis observed in the homozygous tgm was likely due to endoplasmic reticulum stress, resulting in goblet cell damage and compromised mucus production in the colonic epithelial cells in which HLA-DR4/I-E molecules were heavily accumulated. Commensal bacteria seemed to be involved in the accumulation of HLA-DR4/I-E, leading to development of the colitis.
纯合 HLA-DR4/I-E 转基因小鼠(tgm)自发性地发展出类似于人类溃疡性结肠炎的结肠炎。我们探索了由于 HLA-DR4/I-E 的过表达导致结肠上皮细胞内质网应激是否参与结肠炎的发病机制。
建立了主要组织相容性复合体 II 类转录激活物敲除(CIITAKO)背景 tgm,以测试 HLA-DR4/I-E 表达在结肠炎发病机制中的参与。进行了组织学和细胞学分析,并研究了口服分子伴侣牛磺熊脱氧胆酸(TUDCA)和抗生素的效果。还研究了粪便和血清中的 IgA 含量以及存在 IgA 包被的粪便细菌。
仅在结肠炎纯合 tgm 中观察到异常积累的 HLA-DR4/I-E 分子,其伴随着内质网应激标志物结合免疫球蛋白蛋白(BiP)的上调和粘液减少。缺乏 HLA-DR4/I-E 表达的 CIITAKO 纯合 tgm 则不会发生结肠炎。向纯合子口服 TUDCA 可减少结肠上皮细胞中的 HLA-DR4/I-E 和 BiP 表达,并恢复肠道的屏障功能。结肠炎 tgm 的粪便和血清中的 IgA 含量以及 IgA 包被的粪便细菌数量更高,抗生素治疗可抑制 HLA-DR4/I-E 的表达和结肠炎。
在纯合 tgm 中观察到的结肠炎的发病机制可能是由于内质网应激,导致 HLA-DR4/I-E 分子大量积累的结肠上皮细胞中的杯状细胞损伤和粘液产生受损。共生细菌似乎参与了 HLA-DR4/I-E 的积累,导致结肠炎的发生。